Approval · Notice of Compliance 22436 · 2019
ESTROGEL: Notice of Compliance 22436
Issued July 22, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22436
- Date
- July 22, 2019
- Company
- Merck Canada IncKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a primary container closure system, a new pump bottle
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ESTROGEL | Not yet assigned | — |
Medicinal ingredients
- ESTRADIOL HEMIHYDRATE 0.06 PER